The Relationship of Hemoglobin A1c and Diabetic Wound Healing

• Status: Terminated
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will be done to evaluate impact on time to wound closure.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Susan Hassenbein
• Treatments: Ascorbic Acid; Bacitracin; Vitamins

Criteria

Inclusion Criteria:

• >18 years of age

• Diabetic (Type I and Type II)

• Ulceration of the foot at least one centimeter in width/length

• Ulceration at least 0.2 centimeters in depth

Exclusion Criteria:

• Ulceration width/length > 7.5 centimeters

• Wound depth > 1.25 centimeters

• Purulent, excessive drainage and/or other signs of infection (i.e. erythema, edema, warmth)

• Inability to provide informed consent

• Inability to swallow pills (vitamin C supplement)

• Patients with concurrent renal problems

• Patients with medication contraindications to Vitamin C and/or topical wound dressings